ALPHA-HEMOLYSIN VARIANTS AND USES THEREOF

Described herein are variants of alpha-hemolysin having at least one mutation, such as a mutation to a positive charge. In certain examples, the mutation is selected from OK, A1 K, A1 R, D2N, S3K, D4K, D4N, K8R, N47K, E70K, S106K, E1 1 1 N, 127-131 G, D128K, K147N, V149K, E287R, M298A, or combinatio...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
1. Verfasser: CRAIG, Timothy K
Format: Patent
Sprache:eng ; fre
Schlagworte:
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue
container_start_page
container_title
container_volume
creator CRAIG, Timothy K
description Described herein are variants of alpha-hemolysin having at least one mutation, such as a mutation to a positive charge. In certain examples, the mutation is selected from OK, A1 K, A1 R, D2N, S3K, D4K, D4N, K8R, N47K, E70K, S106K, E1 1 1 N, 127-131 G, D128K, K147N, V149K, E287R, M298A, or combinations thereof in the mature, wild-type alpha-hemolysin amino acid sequence. Also provided are compositions including the variants of alpha-hemolysin, nanopore assemblies including the alpha-hemolysin variants, and methods of sequencing nucleic acids incorporating the same. L'invention concerne des variants de l'alpha-hémolysine ayant au moins une mutation, telle qu'une mutation à une charge positive. Dans certains exemples, la mutation est choisie parmi OK, A1 K, A1 R, D2N, S3K, D4K, D4N, K8R, N47K, E70K, S106K, E1 1 1 N, 127-131 G, D128K, K147N, V149K, E287R, M298A, ou des combinaisons de ceux-ci dans la séquence d'acides aminés alpha-hémolysine de type sauvage mature. L'invention concerne également des compositions comprenant les variants d'alpha-hémolysine, des ensembles de nanopores comprenant les variants d'alpha-hémolysine, et des procédés de séquençage d'acides nucléiques les incorporant.
format Patent
fullrecord <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_WO2019166458A1</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>WO2019166458A1</sourcerecordid><originalsourceid>FETCH-epo_espacenet_WO2019166458A13</originalsourceid><addsrcrecordid>eNrjZNB09AnwcNT1cPX194kM9vRTCHMM8nT0CwlWcPRzUQgNdg1WCPFwDXL1d-NhYE1LzClO5YXS3AzKbq4hzh66qQX58anFBYnJqXmpJfHh_kYGhpaGZmYmphaOhsbEqQIAxLglZw</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>ALPHA-HEMOLYSIN VARIANTS AND USES THEREOF</title><source>esp@cenet</source><creator>CRAIG, Timothy K</creator><creatorcontrib>CRAIG, Timothy K</creatorcontrib><description>Described herein are variants of alpha-hemolysin having at least one mutation, such as a mutation to a positive charge. In certain examples, the mutation is selected from OK, A1 K, A1 R, D2N, S3K, D4K, D4N, K8R, N47K, E70K, S106K, E1 1 1 N, 127-131 G, D128K, K147N, V149K, E287R, M298A, or combinations thereof in the mature, wild-type alpha-hemolysin amino acid sequence. Also provided are compositions including the variants of alpha-hemolysin, nanopore assemblies including the alpha-hemolysin variants, and methods of sequencing nucleic acids incorporating the same. L'invention concerne des variants de l'alpha-hémolysine ayant au moins une mutation, telle qu'une mutation à une charge positive. Dans certains exemples, la mutation est choisie parmi OK, A1 K, A1 R, D2N, S3K, D4K, D4N, K8R, N47K, E70K, S106K, E1 1 1 N, 127-131 G, D128K, K147N, V149K, E287R, M298A, ou des combinaisons de ceux-ci dans la séquence d'acides aminés alpha-hémolysine de type sauvage mature. L'invention concerne également des compositions comprenant les variants d'alpha-hémolysine, des ensembles de nanopores comprenant les variants d'alpha-hémolysine, et des procédés de séquençage d'acides nucléiques les incorporant.</description><language>eng ; fre</language><subject>BEER ; BIOCHEMISTRY ; CHEMISTRY ; COMPOSITIONS OR TEST PAPERS THEREFOR ; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL ORENZYMOLOGICAL PROCESSES ; ENZYMOLOGY ; INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIRCHEMICAL OR PHYSICAL PROPERTIES ; MEASURING ; MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEICACIDS OR MICROORGANISMS ; METALLURGY ; MICROBIOLOGY ; MUTATION OR GENETIC ENGINEERING ; ORGANIC CHEMISTRY ; PEPTIDES ; PHYSICS ; PROCESSES OF PREPARING SUCH COMPOSITIONS ; SPIRITS ; TESTING ; VINEGAR ; WINE</subject><creationdate>2019</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20190906&amp;DB=EPODOC&amp;CC=WO&amp;NR=2019166458A1$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,780,885,25564,76547</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20190906&amp;DB=EPODOC&amp;CC=WO&amp;NR=2019166458A1$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>CRAIG, Timothy K</creatorcontrib><title>ALPHA-HEMOLYSIN VARIANTS AND USES THEREOF</title><description>Described herein are variants of alpha-hemolysin having at least one mutation, such as a mutation to a positive charge. In certain examples, the mutation is selected from OK, A1 K, A1 R, D2N, S3K, D4K, D4N, K8R, N47K, E70K, S106K, E1 1 1 N, 127-131 G, D128K, K147N, V149K, E287R, M298A, or combinations thereof in the mature, wild-type alpha-hemolysin amino acid sequence. Also provided are compositions including the variants of alpha-hemolysin, nanopore assemblies including the alpha-hemolysin variants, and methods of sequencing nucleic acids incorporating the same. L'invention concerne des variants de l'alpha-hémolysine ayant au moins une mutation, telle qu'une mutation à une charge positive. Dans certains exemples, la mutation est choisie parmi OK, A1 K, A1 R, D2N, S3K, D4K, D4N, K8R, N47K, E70K, S106K, E1 1 1 N, 127-131 G, D128K, K147N, V149K, E287R, M298A, ou des combinaisons de ceux-ci dans la séquence d'acides aminés alpha-hémolysine de type sauvage mature. L'invention concerne également des compositions comprenant les variants d'alpha-hémolysine, des ensembles de nanopores comprenant les variants d'alpha-hémolysine, et des procédés de séquençage d'acides nucléiques les incorporant.</description><subject>BEER</subject><subject>BIOCHEMISTRY</subject><subject>CHEMISTRY</subject><subject>COMPOSITIONS OR TEST PAPERS THEREFOR</subject><subject>CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL ORENZYMOLOGICAL PROCESSES</subject><subject>ENZYMOLOGY</subject><subject>INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIRCHEMICAL OR PHYSICAL PROPERTIES</subject><subject>MEASURING</subject><subject>MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEICACIDS OR MICROORGANISMS</subject><subject>METALLURGY</subject><subject>MICROBIOLOGY</subject><subject>MUTATION OR GENETIC ENGINEERING</subject><subject>ORGANIC CHEMISTRY</subject><subject>PEPTIDES</subject><subject>PHYSICS</subject><subject>PROCESSES OF PREPARING SUCH COMPOSITIONS</subject><subject>SPIRITS</subject><subject>TESTING</subject><subject>VINEGAR</subject><subject>WINE</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2019</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNrjZNB09AnwcNT1cPX194kM9vRTCHMM8nT0CwlWcPRzUQgNdg1WCPFwDXL1d-NhYE1LzClO5YXS3AzKbq4hzh66qQX58anFBYnJqXmpJfHh_kYGhpaGZmYmphaOhsbEqQIAxLglZw</recordid><startdate>20190906</startdate><enddate>20190906</enddate><creator>CRAIG, Timothy K</creator><scope>EVB</scope></search><sort><creationdate>20190906</creationdate><title>ALPHA-HEMOLYSIN VARIANTS AND USES THEREOF</title><author>CRAIG, Timothy K</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_WO2019166458A13</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng ; fre</language><creationdate>2019</creationdate><topic>BEER</topic><topic>BIOCHEMISTRY</topic><topic>CHEMISTRY</topic><topic>COMPOSITIONS OR TEST PAPERS THEREFOR</topic><topic>CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL ORENZYMOLOGICAL PROCESSES</topic><topic>ENZYMOLOGY</topic><topic>INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIRCHEMICAL OR PHYSICAL PROPERTIES</topic><topic>MEASURING</topic><topic>MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEICACIDS OR MICROORGANISMS</topic><topic>METALLURGY</topic><topic>MICROBIOLOGY</topic><topic>MUTATION OR GENETIC ENGINEERING</topic><topic>ORGANIC CHEMISTRY</topic><topic>PEPTIDES</topic><topic>PHYSICS</topic><topic>PROCESSES OF PREPARING SUCH COMPOSITIONS</topic><topic>SPIRITS</topic><topic>TESTING</topic><topic>VINEGAR</topic><topic>WINE</topic><toplevel>online_resources</toplevel><creatorcontrib>CRAIG, Timothy K</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>CRAIG, Timothy K</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>ALPHA-HEMOLYSIN VARIANTS AND USES THEREOF</title><date>2019-09-06</date><risdate>2019</risdate><abstract>Described herein are variants of alpha-hemolysin having at least one mutation, such as a mutation to a positive charge. In certain examples, the mutation is selected from OK, A1 K, A1 R, D2N, S3K, D4K, D4N, K8R, N47K, E70K, S106K, E1 1 1 N, 127-131 G, D128K, K147N, V149K, E287R, M298A, or combinations thereof in the mature, wild-type alpha-hemolysin amino acid sequence. Also provided are compositions including the variants of alpha-hemolysin, nanopore assemblies including the alpha-hemolysin variants, and methods of sequencing nucleic acids incorporating the same. L'invention concerne des variants de l'alpha-hémolysine ayant au moins une mutation, telle qu'une mutation à une charge positive. Dans certains exemples, la mutation est choisie parmi OK, A1 K, A1 R, D2N, S3K, D4K, D4N, K8R, N47K, E70K, S106K, E1 1 1 N, 127-131 G, D128K, K147N, V149K, E287R, M298A, ou des combinaisons de ceux-ci dans la séquence d'acides aminés alpha-hémolysine de type sauvage mature. L'invention concerne également des compositions comprenant les variants d'alpha-hémolysine, des ensembles de nanopores comprenant les variants d'alpha-hémolysine, et des procédés de séquençage d'acides nucléiques les incorporant.</abstract><oa>free_for_read</oa></addata></record>
fulltext fulltext_linktorsrc
identifier
ispartof
issn
language eng ; fre
recordid cdi_epo_espacenet_WO2019166458A1
source esp@cenet
subjects BEER
BIOCHEMISTRY
CHEMISTRY
COMPOSITIONS OR TEST PAPERS THEREFOR
CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL ORENZYMOLOGICAL PROCESSES
ENZYMOLOGY
INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIRCHEMICAL OR PHYSICAL PROPERTIES
MEASURING
MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEICACIDS OR MICROORGANISMS
METALLURGY
MICROBIOLOGY
MUTATION OR GENETIC ENGINEERING
ORGANIC CHEMISTRY
PEPTIDES
PHYSICS
PROCESSES OF PREPARING SUCH COMPOSITIONS
SPIRITS
TESTING
VINEGAR
WINE
title ALPHA-HEMOLYSIN VARIANTS AND USES THEREOF
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-22T15%3A40%3A36IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=CRAIG,%20Timothy%20K&rft.date=2019-09-06&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EWO2019166458A1%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true